Fingerprint
Dive into the research topics of 'A randomized phase II trial of mitoxantrone, estramustine and vinorelbine or bcl-2 modulation with 13-cis retinoic acid, interferon and paclitaxel in patients with metastatic castrate-resistant prostate cancer: ECOG 3899'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically